Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue 3, 2011, Pages 286-288

  Martin, Stephanie J ^a   Duvic, Madeleine ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cutaneous B cell lymphoma; Cutaneous lymphoid hyperplasia; Intralesional agent; Pseudolymphoma; Rituximab; Tacrolimus

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CLOBETASOL; DOXYCYCLINE; IMIQUIMOD; RITUXIMAB; TACROLIMUS; TRIAMCINOLONE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; CUTANEOUS LYMPHOID HYPERPLASIA; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID HYPERPLASIA; RECURRENT DISEASE; SKIN BIOPSY; TOPICAL TREATMENT; MIDDLE AGED; PATHOLOGY; PSEUDOLYMPHOMA; SKIN DISEASE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MIDDLE AGED; PSEUDOLYMPHOMA; SKIN DISEASES; TREATMENT OUTCOME;

EID: 80053366974     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2011.03.017     Document Type: Article

References (17)

1. M. Nihal, D. Mikkola, and N. Horvath Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential Hum Pathol 34 2003 617 622 (Pubitemid 36750375)
2. N. Anandasabapathy, M. Pulitzer, and W. Epstein Pseudolymphoma evolving into diffuse large B-cell lymphoma Dermatol Online J 14 2008 22
3. R.B. Taylor, J.A. Fortney, and R.B. Pollack Radiation therapy for B-cell cutaneous lymphoid hyperplasia Jpn J Radiol 28 2010 385 387
4. L.M. Good, M.D. Miller, and W.A. High Intralesional agents in the management of cutaneous malignancy: a review J Am Acad Dermatol 2011 64413 64422
5. T. Luger, and C. Paul Potential new indications of topical calcineurin inhibitors Dermatology 215 2007 45 54 (Pubitemid 350308379)
6. A.C. Gilliam, and G.S. Wood Cutaneous lymphoid hyperplasias Semin Cutan Med Surg 19 2000 133 141 (Pubitemid 30448109)
7. A. Dadban, and F. Truchetet Cutaneous lymphoid hyperplasia on a preexistent melanocytic nevus Dermatology 217 2008 199 200
8. T.E. Witzig, D.J. Inwards, and T.M. Habermann Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab Mayo Clin Proc 82 2007 692 699 (Pubitemid 46878092)
9. J. Valencak, F. Weihsengruber, and K. Rappersberger Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients Ann Oncol 20 2009 326 330
10. M. Seker, B.B. Ustaalioglu, and A. Bilici Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma Leuk Res 34 2010 160 163
11. A.V. Morales, R. Advani, and S.M. Horwitz Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab J Am Acad Dermatol 59 2008 953 957
12. E. Hammer, O. Sangueza, and P. Suwanjindar Immunophenotypic and genotypic analysis in cutaneous lymphoid hyperplasias J Am Acad Dermatol 28 1993 426 433 (Pubitemid 23075258)
13. S. Tomar, H.L. Stoll, and M.A. Grassi Treatment of cutaneous pseudolymphoma with interferon alfa-2b J Am Acad Dermatol 60 2009 172 174
14. H. Benchikhi, C. Bodemer, and S. Fraitag Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases J Am Acad Dermatol 40 1999 1005 1007 (Pubitemid 29268937)
15. S. Guis, J.M. Schiano de Colella, and N. Bonnet Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept Eur J Dermatol 18 2008 474 476 (Pubitemid 352031873)
16. R. Fink-Puches, I.H. Wolf, and I. Zalaudek Treatment of primary cutaneous B-cell lymphoma with rituximab J Am Acad Dermatol 52 2005 847 853 (Pubitemid 40614650)
17. T. Paul, P. Radny, and S.M. Kröber Intralesional rituximab for cutaneous B-cell lymphoma Br J Dermatol 144 2001 1239 1243 (Pubitemid 34204220)